Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global E Online Ltd (GLBE) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance

Global E Online LtdTrade
Roivant Sciences Ltd. Common SharesTrade

Price performance (Past 24H)

Key statistics

Global E Online Ltd vs Roivant Sciences Ltd. Common Shares — how do they compare? Global E Online Ltd trades at $40.37 (market cap $6.75B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 3.7× Global E Online Ltd's market cap, and Global E Online Ltd is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global E Online Ltd for 21 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.

GLBEROIV
Market Cap
$6.75B$24.72B
Volume
1,468,7086,279,442
Sector
Consumer CyclicalHealth
52-Week High
$42.36$41.81
52-Week Low
$27.54$16.04
Typical Hold Time
21 Days1 Days
Enterprise Value
$6.24B$20.99B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global E Online Ltd

GLBE trades at $40.25, up 3.31% today, with a bullish technical signal from moving averages and strong analyst consensus. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth of 39% year-over-year. Recent news includes the appointment of a new Chief Revenue Officer and significant insider selling by executives.

The outlook is positive, supported by strong revenue growth, expanding margins, and a high analyst buy rating. Key risks include elevated valuation multiples, insider selling pressure, and dependence on e-commerce market conditions. The stock offers potential upside to the consensus price target of $48.86.

Roivant Sciences Ltd. Common Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Global E Online Ltd

Global-e provides a platform for cross-border e-commerce, helping retailers increase international sales by localizing the shopping experience for consumers in over 200 destinations worldwide.

Read more on GLBE →

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →